Hiroyuki Sato

8PUBLICATIONS

33CO-AUTHORS

Predictive and prognostic markersCancer diagnosisPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 30, 2026

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

|Jun 08, 2026

Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects.

|Jun 07, 2026

Risk of Insomnia Disorder in Japanese Cancer Patients: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data.

|May 10, 2026

Evolving Variants, Shifting Outcomes: Implications for Nonconcurrent Controls in Platform Trials for COVID-19.

|Mar 19, 2026

Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence Synthesis.

Yosuke Yasuda, Soichiro Yoshida, Shugo Yajima

|Jan 22, 2026

Bayesian Power Prior in Platform Trials With Non-Concurrent Control for Binary Outcomes: Development and Comparative Evaluation.

Junichi Asano, Hiroyuki Sato, Shin Watanabe

Pageof 2

Frequent Collaborators

Akihiro Hirakawa

Hajime Tanaka

Soichiro Yoshida

Wei Chen

Tadashi Hosoya

Takayuki Kanno

Hitoshi Masuda

Takashi Satoh

Yasuhiro Otomo

Tadaki Suzuki

Frequent Collaborators

Akihiro Hirakawa

Hajime Tanaka

Soichiro Yoshida

Wei Chen